Surgical Oncology
Volume 15, Issue 1 , Pages 1-12 , July 2006

Colorectal cancer follow-up: Useful or useless?

References 

  1. Connor S, Frizelle FA, Bagshaw PF. Follow-up after attempted curative surgery for colorectal cancer; postal survey of New Zealand surgeons’ practice. New Zealand Medical Journal. 2001;114(1129):151–153
  2. Florey CDV, Yule B, Fogg A, Napier A, Orbell S, Cuschieri A. A randomized trial of immediate discharge of surgical patients to general practice. Journal of Public Health Medicine. 1994;16(4):455–464
  3. Foster ME, Hill J, Leaper DJ. Follow-up after colo-rectal cancer. Current practice in Wales and south-west England. International Journal of Colorectal Dimension. 1987;2(2):118–119
  4. McArdle C. ABC of colorectal cancer: effectiveness of follow up. British Medical Journal. 2000;321(7272):1332–1335
  5. Mella J, Datta SN, Biffin A, Radcliffe AG, Steele RJ, Stamatakis JD. Surgeons’ follow-up practice after resection of colorectal cancer. Annals of the Royal College of Surgeons of England. 1997;79(3):206–209
  6. Simpson H, Jeffery M, Hickey B, Frizelle F, Frampton C. Postoperative follow-up strategies for patients after potentially curative surgery for colorectal cancer at Christchurch Hospital. New Zealand Medical Journal. 2004;117(1193):U873
  7. Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Diseases of the Colon and Rectum. 1994;37(6):573–583
  8. Earle CC, Grunfeld E, Coyle D, Cripps MC, Stern HS. Cancer physicians’ attitudes toward colorectal cancer follow-up. Annals of Oncology. 2003;14(3):400–405
  9. Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. European Journal of Surgical Oncology. 2000;26(4):322–328
  10. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA. 1992;268(17):2420–2425
  11. Lohr KN. Guidelines for clinical practice: what they are and why they count. Journal of Law Medicine & Ethics. 1995;23(1):49–56
  12. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Annals of Internal Medicine. 1998;129(1):27–35
  13. Anthony T, Fleming JB, Bieligk SC, Sarosi GA, Kim LT, Gregorcyk SG, et al. Postoperative colorectal cancer surveillance. Journal of the American College of Surgeons. 2000;190(6):737–749
  14. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. Journal of Gastrointestinal Surgery. 2005;9(3):320–328
  15. Turk PS, Wanebo HJ. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer. 1993;71(suppl. 12):4267–4277
  16. Anthony T, Simmang C, Hyman N, Buie D, Kim D, Cataldo P, et al. Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Diseases of the Colon and Rectum. 2004;47(6):807–817
  17. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scandinavian Journal of Gastroenterology. 1999;34(5):509–515
  18. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy. Annals of Surgery. 1998;228(1):59–63
  19. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26
  20. Guthrie JA. Colorectal cancer: follow-up and detection of recurrence. Abdominal Imaging. 2002;27(5):570–577
  21. Kronborg O. Colorectal cancer follow-up. European Journal of Surgical Oncology. 2000;26(4):321
  22. Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Annals of Oncology. 1997;8(11):1081–1087
  23. Simpson H, Jeffery M, Hickey B, Frizelle F, Frampton C. Postoperative follow-up strategies for patients after potentially curative surgery for colorectal cancer at Christchurch hospital. New Zealand Medical Journal. 2004;117(1193):U873
  24. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Seminars in Oncology. 2003;30(3):349–360
  25. Kievit J. Follow-up of patients with colorectal cancer; numbers needed to test and treat. European Journal of Cancer. 2002;38(7):986–999
  26. Secco GB, Fardelli R, Giaquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. European Journal of Surgical Oncology. 2002;28(4):418–423
  27. Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet. 2000;355(9201):395–399
  28. Borie F, Combescure C, Daurès JP, Trétarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using Markov model. World Journal of Surgery. 2004;28(6):563–569
  29. Scholefield JH, Steele RJ. Guidelines for follow up after resection of colorectal cancer. Gut. 2002;51(Suppl. 5):V3–V5
  30. Staib L, Link KH, Beger HG. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Archives of Surgery. 2000;385(6):412–420
  31. Pfister DG, Benson AB, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. New England Journal of Medicine. 2004;350(23):2375–2382
  32. Cochrane JP, Williams JT, Faber RG, Slack WW. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. British Medical Journal. 1980;280(6214):593–595
  33. Li Destri G, Craxi G, Rinzivillo C, Bonanno G, Di Cataldo A, Puleo S, et al. Colorectal follow-up. Our experience. Chirurgia. 1996;9(3):261–267
  34. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114(1):7–14
  35. Camunas J, Enriquez JM, Devesa JM, Morales V, Millan I. Value of follow-up in the management of recurrent colorectal cancer. European Journal of Surgical Oncology. 1991;17(5):530–535
  36. Desch CE, Benson AB, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. Journal of Clinical Oncology. 1999;17(4):1312–1321
  37. Audisio RA, Robertson C. Colorectal cancer follow-up: perspectives for future studies. European Journal of Surgical Oncology. 2000;26(4):329–337
  38. Steele G. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer. 1993;71(Suppl. 12):4225–4235
  39. Kievit J, Bruinvels D. Detection of recurrence after surgery for colorectal cancer. European Journal of Cancer. 1995;31A(7–8):1222–1225
  40. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813
  41. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database System Review. 2002;(1):CD002200
  42. Rosen M, Chan L, Beart RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Diseases of the Colon and Rectum. 1998;41(9):1116–1126
  43. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Annals of Surgery. 1994;219(2):174–182
  44. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomised comparison with no follow-up. Diseases of the Colon and Rectum. 1995;38(6):619–626
  45. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrence of colorectal cancer. Diseases of the Colon and Rectum. 1998;41(9):1127–1133
  46. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. British Journal of Surgery. 1997;84(5):666–669
  47. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Archives of Surgery. 1995;130(10):1062–1067
  48. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Mechanisms of improved survival from intensive follow-up in colorectal cancer: a hypothesis. British Journal of Cancer. 2005;92(3):430–433
  49. Giovagnoni A, Ottaviani L, Mensa A, Durastanti M, Floriani I, Cascinu S. Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma. Radiol Med (Torino). 2005;109(4):345–357
  50. Hookman P, Barkin JS. The role of vigorous detection of recurrence after curative resection of colorectal cancer. American Journal of Gastroenterology. 1998;93(12):2624–2627
  51. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. New England Journal of Medicine. 1997;337(8):536–542
  52. Hohenberger P. Colorectal cancer—what is standard surgery?. European Journal of Cancer. 2001;37(Suppl. 7):S173–S187
  53. Soybel DI. Careful follow-up for patients undergoing curative resections in colorectal carcinoma: how careful is “careful”?. Gastroenterology. 1998;114(1):220–221
  54. Chau I, Allen MJ, Cunningham D, Norman AR, Brown G, Ford HE, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. Journal of Clinical Oncology. 2004;22(8):1420–1429
  55. Ohlsson B, Palsson B. Follow-up after colorectal cancer surgery. Acta Oncologica. 2003;42(8):816–826
  56. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Journal of Clinical Oncology. 1992;10(6):904–911
  57. Rougier P, Lepere C. Metastatic colorectal cancer: first- and second-line treatment in 2005. Seminars in Oncology. 2005;32(6 Suppl. 8):15–20
  58. Saltz LB. Metastatic colorectal cancer: is there one standard approach?. Oncology (Williston Park). 2005;19(9):1147–1154
  59. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005;10(4):250–261
  60. Braun AH, Achterrath W, Wilke H, Vanhoefer U, Harstrick A, Preusser P. New systemic frontline treatment for metastatic colorectal carcinoma. Cancer. 2004;100(8):1558–1577
  61. Christopoulou A. Chemotherapy in metastatic colorectal cancer. Techniques in Coloproctology. 2004;8(Suppl. 1):s43–s46
  62. Damjanovic D, Thompson P, Findlay MP. Evidence-based update of chemotherapy options for metastatic colorectal cancer. ANZ Journal of Surgery. 2004;74(9):781–787
  63. Hoff PM, Pazdur R. Progress in the development of novel treatments for colorectal cancer. Oncology (Williston Park). 2004;18(6):705–708
  64. Kohne CH, Bruce C, Folprecht G, Audisio R. Role of new agents in the treatment of colorectal cancer. Surgical Oncology—Oxford. 2004;13(2–3):75–81
  65. Park DJ, Stoehlmacher J, Lenz HJ. Tailoring chemotherapy in advanced colorectal cancer. Current Opinion in Pharmacology. 2003;3(4):378–385
  66. Coutinho AK, Rocha Lima CM. Metastatic colorectal cancer: systemic treatment in the new millennium. Cancer Control. 2003;10(3):224–238
  67. Van Cutsem E, Verslype C, Demedts I. The treatment of advanced colorectal cancer: where are we now and where do we go?. Best Practice & Research in Clinical Gastroenterology. 2002;16(2):319–330
  68. Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O’Fallon JR, Erlichman C, et al. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology. 1997;54(4):287–292
  69. Li Destri G, Rinzivillo C, Craxi G, La Greca G, Di Cataldo A, Puleo S, et al. Colorectal follow-up planning modified on the basis of our personal experience. Digestive Surgery. 1998;15(1):64–68
  70. Li Destri G, Sgroi A, Di Cataldo A, Puleo S, Minutolo V, Licata A. Rectal cancer: a follow-up planned on the basis of the acquired experience. Journal of Tumor Marker Oncology. 2003;18:153–159
  71. Sugarbaker PH, Gianola FJ, Dwyer A, Neuman NR. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery. 1987;102(1):79–87
  72. Northover J. Realism or nihilism in bowel cancer follow-up?. Lancet. 1998;351(9109):1074–1076
  73. Boulin M, Lejeune C, Le Teuff G, Binquet C, Bouvier AM, Bedenne L, et al. Patterns of surveillance practices after curative surgery for colorectal cancer in a French population. Diseases of the Colon and Rectum. 2005;48(10):1890–1899
  74. Li Destri G, Sapienza S, Rodolico M, Di Cataldo A, Puleo S, Minutolo V, et al. Stress of routine follow-up in colorectal cancer operated patients. Chirurgia Italiana. 2000;52(6):695–698
  75. Papagrigoriadis S, Heyman B. Patients’ views on follow up of colorectal cancer: implications for risk communication and decision making. Postgraduate Medical Journal. 2003;79(933):403–407
  76. Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. British Journal of Cancer. 1997;75(6):914–920
  77. Kiebert GM, Welvaart K, Kievit J. Psychological effects of routine follow up on cancer patients after surgery. European Journal of Surgery. 1993;159(11–12):601–607
  78. Kuchler T, Henne-Bruns D, Rappat S, Graul J, Holst K, Williams JI, et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology. 1999;46(25):322–335
  79. Nordin K, Glimelius B. Psychological reactions in newly diagnosed gastrointestinal cancer patients. Acta Oncologica. 1997;36(8):803–810
  80. Rocklin MS, Senagore AJ, Talbott TM. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Diseases of the Colon and Rectum. 1991;34(9):794–797
  81. Kronborg O. Optimal follow-up in colorectal cancer patients: what tests and how often?. Seminars in Surgical Oncology. 1994;10(3):217–224
  82. Virgo KS, Wade TP, Longo WE, Coplin MA, Vernava AM, Johnson FE. Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Annals of Surgical Oncology. 1995;2(6):472–482
  83. Benson AB, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, et al. American Society of Clinical Oncology. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. Journal of Clinical Oncology. 2000;18(20):3586–3588
  84. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Diseases of the Colon and Rectum. 1994;37(9):875–881
  85. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993;270(8):943–947
  86. Li Destri G, Greco S, Rinzivillo C, Racalbuto A, Curreri R, Di Cataldo A. Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?. Surgery Today. 1998;28(12):1233–1236
  87. Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Diseases of the Colon and Rectum. 2005;48(4):744–748
  88. Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Diseases of the Colon and Rectum. 1993;36(11):1063–1068
  89. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110(1):13–29
  90. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colorectal metastases. Journal of Clinical Oncology. 1997;15(3):938–946
  91. Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Annals of Thoracic Surgery. 2004;78(1):238–244
  92. Minton JP, Hoehn JL, Gerber DM, Horsley JS, Connolly DP, Salwan F, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer. 1985;55(6):1284–1290
  93. Northover J. Follow-up after curative surgery for colorectal cancer. Scandinavian Journal of Surgery. 2003;92(1):84–89
  94. Safi F, Beyer HG. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detection and Prevention. 1993;17(3):417–424
  95. Fletcher RH. Carcinoembryonic antigen. Annals of Internal Medicine. 1986;104(1):66–73
  96. Sugihara K, Yamamoto J. Surgical treatment of colorectal liver metastases. Annales Chirurgiae et Gynaecologiae. 2000;89(3):221–224
  97. Penna C, Nordlinger B. Colorectal metastasis (liver and lung). Surgical Clinics of North America. 2002;82(5):1075–1090
  98. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993;71(Suppl. 12):4252–4266
  99. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology. 2002;224(3):748–756
  100. Scott DJ, Guthrie JA, Arnold P, Ward J, Atchley J, Wilson D, et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clinical Radiology. 2001;56(3):235–242
  101. Ntinas A, Zambas N, Al Mogrambi S, Petras P, Chalvatzoulis E, Frangandreas G, et al. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers. Techniques in Coloproctology. 2004;8(Suppl. 1):S190–S192
  102. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Diseases of the Colon and Rectum. 2002;45(4):476–484
  103. Wernecke K, Rummeny E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR American Journal of Roentgenology. 1991;157(4):731–739
  104. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. British Journal of Surgery. 1988;75(7):641–644
  105. De Salvo L, Razzetta F, Arezzo A, Tassone U, Bogliolo G, Bruzzone D, et al. Surveillance after colorectal cancer surgery. European Journal of Surgical Oncology. 1997;23(6):522–525
  106. Howell JD, Wotherspoon H, Leen E, Cooke TC, McArdle CS. Evaluation of a follow-up programme after curative resection for colorectal cancer. British Journal of Cancer. 1999;79(2):308–310
  107. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Annals of Surgical Oncology. 2001;8(4):347–353
  108. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology. 2004;22(1):23–30
  109. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344(8932):1255–1260
  110. Smith TJ, Bear HD. Standard follow-up of colorectal cancer patients: finally, we can make practice guidelines based on evidence. Gastroenterology. 1998;114(1):211–213
  111. Barkin JS, Cohen ME, Flaxman M, Lindblad AS, Mayer RJ, Kalser MH, et al. Value of a routine follow-up endoscopy program for the detection of recurrent colorectal carcinoma. American Journal of Gastroenterology. 1988;83(12):1355–1360
  112. Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, et al. Surgical resection of locally recurrent colorectal adenocarcinoma. British Journal of Surgery. 1998;85(3):372–376
  113. Roncucci L. Local recurrences of rectal cancer. Minerva Chirurgica. 2005;60(3):167–178
  114. Fleischer DE, Goldberg SB, Browning TH. Detection and surveillance of colorectal cancer. JAMA. 1989;261(4):580–585
  115. Audisio R, Setti-Carraro P, Segala M, Capko D, Androni B, Tiberio G. Follow-up in colorectal cancer patients: a cost-benefit analysis. Annals of Surgical Oncology. 1996;3(4):349–357
  116. Romano G, Belli G, Rotondano G. Colorectal cancer. Diagnosis of recurrence. Gastrointestinal Endoscopy Clinics of North America. 1995;5(4):831–841
  117. Hunerbein M, Totkas S, Moesta KT, Ulmer C, Handke T, Schlag PM. The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery. 2001;129(2):164–169
  118. Kanyari Z, Orosz L, Juhasz B, Tanyi M, Nemeth E, Tron L, et al. The role of positron emission tomography (PET) in the detection of local recurrence and metastases of colorectal cancer. Magyar Sebeszet. 2005;58(3):179–183
  119. Lamy PJ, Comte F, Eberle MC. Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients. Bulletin du Cancer. 2005;92(10):858–864
  120. Liu FY, Chen JS, Changchien CR, Yeh CY, Liu SH, Ho KC, et al. Utility of 2-fluoro-2-deoxy-d-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Diseases of the Colon and Rectum. 2005;48(10):1900–1912
  121. Kim JH, Czernin J, Allen-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR, et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. Journal of Nuclear Medicine. 2005;46(4):587–595
  122. Borrego Dorado I, Gomez Camarero P, Ruiz Franco-Baux J, Vazquez Albertino R. Evaluation of efficacy and clinical impact of FDG-PET in patients with suspicion of recurrent colorectal cancer. Revista espanola de Medicina Nuclear. 2004;23(5):313–323
  123. Kula Z, Szefer J, Zuchora Z, Romanowicz G, Pietrzak T. Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer. Polski Merkuriusz Lekarski. 2004;17(Suppl. 1):63–66
  124. Rosa F, Meimarakis G, Stahl A, Bumm R, Hahn K, Tatsch K, et al. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin. 2004;43(4):135–140
  125. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Annals of Surgery. 2004;240(6):1027–1034
  126. Wiering B, Ruers TJ, Oyen WJ. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Review of Anticancer Therapy. 2004;4(4):607–613
  127. Dimitrakopoulou-Strauss A, Strauss LG, Rudi J. PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Quarterly Journal of Nuclear Medicine. 2003;47(1):8–13
  128. Lan YT, Lin JK, Li AF, Lin TC, Chen WS, Jiang JK, et al. Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. International Journal of Colorectal Disease. 2005;20(2):121–125
  129. Fajobi O, Yiu CY, Sen-Gupta SB, Boulos PB. Metachronous colorectal cancers. British Journal of Surgery. 1998;85(7):897–901
  130. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Diseases of the Colon and Rectum. 1994;37(6):568–572
  131. Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New England Journal of Medicine. 1993;329(27):1977–1981
  132. McCormack PM, Ginsberg RJ. Current management of colorectal metastases to lung. Chest Surgical Clinics of North America. 1998;8(1):119–126
  133. Inoue M, Kotake Y, Nakagawa K, Fujiwara K, Fukuhara K, Yasumitsu T. Surgery for pulmonary metastases from colorectal carcinoma. Annals of Thoracic Surgery. 2000;70(2):380–383
  134. McAfee MK, Allen MS, Trastek VF, Ilstrup DM, Deschamps C, Pairolero PC. Colorectal lung metastases: results of surgical excision. Annals of Thoracic Surgery. 1992;53(5):780–785
  135. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. American Society of Clinical Oncology. American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology. 2005;23(33):8512–8519
  136. Engstrom P. Update: NCCN colon cancer clinical practice guidelines. Journal of the National Comprehensive Cancer Network: JNCCN. 2005;3(Suppl. 1):S25–S28
  137. Benson AB, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, et al. National Comprehensive Cancer Network. NCCN Practice Guidelines for Colorectal Cancer. Oncology. 2000;14(11A):203–212
  138. Van Cutsem EJ, Kataja VV. ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Annals of Oncology. 2005;16(Suppl. 1):i16–i17
  139. Tveit KM, Kataja VV. ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Annals of Oncology. 2005;16(Suppl. 1):i20–i21
  140. Hermanek P, Junginger T, Hossfeld DK, Muller RP, Folsch UR. Follow-up and rehabilitation for patients with gastrointestinal tumors. Dtsch Arztebl. 1999;96:A2084–A2088
  141. Johnson FE, Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS. How tumor stage affects surgeons’ surveillance strategies after colon cancer surgery. Cancer. 1995;76(8):1325–1329
  142. Yamamoto S, Akasu T, Fujita S, Moriya Y. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?. Hepatogastroenterology. 2005;52(62):444–449
  143. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. Resection of the liver for colorectal metastases: a multi-institutional study of indicators for resection. Surgery. 1986;100(2):278–284
  144. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995;273(23):1837–1841
  145. Epstein RJ. Does the breast cancer dollar make sense?. European Journal of Cancer. 1992;28(2–3):486–491
  146. Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. Journal of Clinical Oncology. 2004;22(23):4829–4836
  147. Earle CC, Chapman RH, Baker CS, Bell CM, Stone PW, Sandberg EA, et al. Systematic overview of cost-utility assessments in oncology. Journal of Clinical Oncology. 2000;18(18):3302–3317
  148. Michel P, Merle V, Chiron A, Ducrotte P, Paillot B, Hecketsweiler P, et al. Postoperative management of stage II/III colon cancer: a decision analysis. Gastroenterology. 1999;117(4):784–793
  149. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Annals of Internal Medicine. 2002;137(2):96–104

PII: S0960-7404(06)00025-9

doi: 10.1016/j.suronc.2006.06.001

Surgical Oncology
Volume 15, Issue 1 , Pages 1-12 , July 2006

Article Tools